June 11, 2015JAMA Oncology10 citations
Therapy for Hematologic Cancers in Older Patients, Quality of Life, and Health Economics
View Full Paper
Key Points
Key points are not available for this paper at this time.
Abstract
Deeg and Steuten address the financial, societal, and individual costs of aggressive treatment with curative intent in older patients with hematologic cancers and suggest that in some cases, palliative care might be a preferred alternative.
Cite This Study
Deeg et al. (2015) studied this question.